ACELA BIO

Serial Number 90059449
Registration 7202374
700

Registration Progress

Application Filed
Jul 17, 2020
Under Examination
Aug 22, 2023
Approved for Publication
Jun 27, 2023
Published for Opposition
Jun 27, 2023
Registered
Oct 24, 2023

Trademark Image

ACELA BIO

Basic Information

Serial Number
90059449
Registration Number
7202374
Filing Date
July 17, 2020
Registration Date
October 24, 2023
Published for Opposition
June 27, 2023
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 24, 2023
Registration
Registered
Classes
042

Rights Holder

ACELABIO (US) INC.

03
Address
Suite 110
10581 Roselle Street
San Diego, CA 92121

Ownership History

ACELABIO (US) INC.

Original Applicant
03
San Diego, CA

ACELABIO (US) INC.

Owner at Publication
03
San Diego, CA

ACELABIO (US) INC.

Original Registrant
03
San Diego, CA

Legal Representation

Attorney
Kathryn E. Garipay

USPTO Deadlines

Next Deadline
1553 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-10-24)
Due Date
October 24, 2029
Grace Period Ends
April 24, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

34 events
Date Code Type Description Documents
Oct 24, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 24, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 19, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 18, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 18, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 18, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Sep 11, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 11, 2023 IUAF S USE AMENDMENT FILED Loading...
Aug 22, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 27, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 27, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 7, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 22, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 5, 2023 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Nov 1, 2022 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
May 4, 2022 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Nov 4, 2021 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Nov 2, 2021 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
May 5, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 5, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 5, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 30, 2021 CNSL R SUSPENSION LETTER WRITTEN Loading...
Apr 30, 2021 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Apr 30, 2021 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Apr 29, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 29, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 29, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 2, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 2, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 2, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 29, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 15, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 14, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 21, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Conducting research in support of human clinical trials, which may include analysis of biospecimens from pre-clinical or animal testing; analysis of biospecimens at the protein, DNA or RNA level for discovery and/or development of disease activity measures or biomarkers; histopathology based testing services; histopathology support services, namely, reviewing and scoring tissue sample images provided by others; Processing of biopsy tissue to allow for blocking and sectioning with preparation and staining of glass slides; Preparing and staining glass slides for scientific and medical research purposes; converting glass slides to digital slides, and analyzing digital slides for scientific and medical research purposes
First Use Anywhere: 20210700
First Use in Commerce: 20210700

Additional Information

Design Mark
The mark consists of the stylized wording "ACELA BIO" and a stylized design of a microscope.

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIO"